Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh
Authors:
- Abdur Razzaque SarkerASAbdur Razzaque Sarker
- Ziaul IslamZIZiaul Islam
- Iqbal Ansary KhanIKIqbal Ansary Khan
- Amit SahaASAmit Saha
- Fahima ChowdhuryFCFahima Chowdhury
- Ashraful Islam KhanAKAshraful Islam Khan
- Alejandro CraviotoACAlejandro Cravioto
- John David ClemensJCJohn David Clemens
- Firdausi QadriFQFirdausi Qadri
- Jahangir A.M. KhanJKJahangir A.M. Khan
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation
This publication has 14 references indexed in Scilit:
- Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, BangladeshVaccine, 2013
- Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspectiveBMC Infectious Diseases, 2013
- Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled TrialPLOS Neglected Tropical Diseases, 2011
- Costs of illness due to endemic choleraEpidemiology and Infection, 2011
- Cost–benefit comparisons of investments in improved water supply and cholera vaccination programsVaccine, 2009
- The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countriesVaccine, 2008
- Costs of running a universal adolescent hepatitis B vaccination programmeVaccine, 2005
- A cost benefit analysis of routine varicella vaccination in SpainVaccine, 1999
- A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.International Journal of Epidemiology, 1997
- Users' Guides to the Medical LiteratureJAMA, 1995